1st Quarter - Report

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Period 1st Quarter 2010 Filed Apr 20, 2010 Signed by Andrew Fish, Senior Vice President Legal and Government Affairs

Official filing
Firm
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
Client
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
Income
—
Expenses
$423,644
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Financial Institutions/Investments/Securities FIN

HR 4173, S. 3217

LobbyistCovered position, as disclosed
ANDREW FISH —
JUSTIN EDWARD NEUMANN —
ALLEN SEGAL —

Contacted: Office of Natl Drug Control Policy (NDCP); SENATE; Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES

Bills named: S. 3217 (111th), H.R. 4173 (111th)

Alcohol and Drug Abuse ALC

HR 1259 & S 1383 - Dextromethorphan Abuse S. 256 & HR 2923 - Methamphetamine Abuse

LobbyistCovered position, as disclosed
ANDREW FISH —
JUSTIN EDWARD NEUMANN —
ALLEN SEGAL —

Contacted: Drug Enforcement Administration (DEA); SENATE; Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES

Bills named: S. 256 (111th), H.R. 2923 (111th), H.R. 1259 (111th)

Health Issues HCR

HR 3590 - Patient Protection and Affordable Care Act HR 3962 - America's Affordable Health Choices Act

LobbyistCovered position, as disclosed
ANDREW FISH —
JUSTIN EDWARD NEUMANN —
ALLEN SEGAL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Office of Natl Drug Control Policy (NDCP)

Bills named: H.R. 3590 (111th), H.R. 3962 (111th)

Food Industry (safety, labeling, etc.) FOO

HR 2749 & S. 510 - Food Safety S. 3002 - supplements

LobbyistCovered position, as disclosed
ANDREW FISH —
JUSTIN EDWARD NEUMANN —
ALLEN SEGAL —

Contacted: Office of Natl Drug Control Policy (NDCP); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 510 (111th), S. 3002 (111th), H.R. 2749 (111th)

Pharmacy PHA

Status of Pseudoephedrine HR 759 - drug safety S 882 - drug safety

LobbyistCovered position, as disclosed
ANDREW FISH —
JUSTIN EDWARD NEUMANN —
ALLEN SEGAL —

Contacted: Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; SENATE; Office of Natl Drug Control Policy (NDCP)

Bills named: H.R. 759 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.